SCYNEXIS Inc. Company Profile
NASDAQ: SCYXHealthcareDrug Manufacturers - Specialty & GenericUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
SCYNEXIS at a glance
SCYNEXIS Inc. (NASDAQ: SCYX) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector headquartered in Jersey City, NJ. SCYNEXIS is led by Dr. David Gonzalez Angulo M.D. and employs about 18 people. The company's shares have traded publicly since 2014.
At a market capitalization of $42.0 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001178253, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does SCYNEXIS do?
SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
Business description based on the company's public filings.
Company information
- Legal name
- SCYNEXIS Inc.
- Ticker
- NASDAQ: SCYX
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Dr. David Gonzalez Angulo M.D.
- Employees
- 18
- Headquarters
- 1 Evertrust Plaza, Jersey City, NJ, United States
- Phone
- 201 884 5485
- Website
- scynexis.com
- IPO year
- 2014
- Market cap
- $41.99M
- SEC CIK
- 0001178253
Companies similar to SCYNEXIS
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CPHIChina Pharma Holdings Inc. | 0.96 | +12.94% | $41.30M | vs SCYX |
| IXHLIncannex Healthcare Inc. | 3.20 | +0.63% | $40.14M | vs SCYX |
| RMTIRockwell Medical Inc. | 8.02 | -2.43% | $32.32M | vs SCYX |
| ZYBTZhengye Biotechnology Holding Limited Class A | 1.15 | -0.87% | $54.50M | vs SCYX |
| TLPHTalphera Inc. | 1.08 | +2.86% | $56.06M | vs SCYX |
| SHPHShuttle Pharmaceuticals Holdings Inc. | 5.55 | +17.83% | $26.44M | vs SCYX |
| OPTHOptimi Health Corp. | 4.09 | 0.00% | $23.39M | vs SCYX |
| TXMDTherapeuticsMD Inc. | 2.01 | +0.50% | $23.26M | vs SCYX |